Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases

Abstract

Interstitial lung disorders are a group of respiratory diseases characterized by interstitial compartment infiltration, varying degrees of infiltration, and fibrosis, with or without small airway involvement. Although some are idiopathic (e.g., idiopathic pulmonary fibrosis, idiopathic interstitial pneumonias, and sarcoidosis), the great majority have an underlying etiology, such as systemic autoimmune rheumatic disease (SARD, also called Connective Tissue Diseases or CTD), inhalational exposure to organic matter, medications, and rarely, genetic disorders. This review focuses on diagnostic approaches in interstitial lung diseases associated with SARDs. To make an accurate diagnosis, a multidisciplinary, personalized approach is required, with input from various specialties, including pulmonary, rheumatology, radiology, and pathology, to reach a consensus. In a minority of patients, a definitive diagnosis cannot be established. Their clinical presentations and prognosis can be variable even within subsets of SARDs.

Keywords

systemic autoimmune rheumatic diseases - interstitial lung diseases - screening - diagnosis - pulmonary function tests - high-resolution computed tomography - artificial intelligence

Publication History

Article published online:
17 April 2024

• References

• 1 Mira-Avendano I, Abril A, Burger CD. et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clin Proc 2019; 94 (02) 309-325
• 2 Travis WD, Costabel U, Hansell DM. et al. ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2013; 188 (06) 733-748
• 3 Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138 (02) 251-256
• 4 Homma Y, Ohtsuka Y, Tanimura K. et al. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia?. Respiration 1995; 62 (05) 248-251
• 5 Kinder BW, Collard HR, Koth L. et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 2007; 176 (07) 691-697
• 6 Vij R, Strek ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 2013; 143 (03) 814-824
• 7 American College of Rheumatology. Interstitial Lung Disease Guideline. Available at: https://rheumatology.org/interstitial-lung-disease-guideline . Accessed February 25, 2024
• 8 Fischer A, Antoniou KM, Brown KK. et al. “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46 (04) 976-987
• 9 Huapaya JA, Boulougoura A, Fried J. et al. Long-term evaluation of pulmonary function and survival of patients with interstitial pneumonia with autoimmune features. Clin Exp Rheumatol 2023; 41 (01) 15-23
• 10 Joerns EK, Adams TN, Newton CA. et al. Variables associated with response to therapy in patients with interstitial pneumonia with autoimmune features. J Clin Rheumatol 2022; 28 (02) 84-88
• 11 Hoffmann-Vold AM, Maher TM, Philpot EE. et al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol 2020; 2 (02) e71-e83
• 12 Lee AS, Ryu JH. Aspiration pneumonia and related syndromes. Mayo Clin Proc 2018; 93 (06) 752-762
• 13 Salvioli B, Belmonte G, Stanghellini V. et al. Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 2006; 38 (12) 879-884
• 14 Cottin V, Cordier JF. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis?. Eur Respir J 2012; 40 (03) 519-521
• 15 Manfredi A, Cassone G, Vacchi C. et al. Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases. Arch Rheumatol 2020; 36 (01) 19-25
• 16 Steele R, Hudson M, Lo E, Baron M. Canadian Scleroderma Research Group. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken) 2012; 64 (04) 519-524
• 17 Schraufnagel DEMF. History and physical examination. In: Murray and Nadel's Textbook of Respiratory Medicine. 5th ed.. Elsevier Saunders; 2010
• 18 Shiraishi K, Jinta T, Nishimura N. et al. Digital clubbing is associated with higher serum KL-6 levels and lower pulmonary function in patients with interstitial lung disease. Can Respir J 2018; 2018: 3640967
• 19 van Manen MJG, Vermeer LC, Moor CC. et al. Clubbing in patients with fibrotic interstitial lung diseases. Respir Med 2017; 132: 226-231
• 20 Aparicio IJ, Lee JS. Connective tissue disease-associated interstitial lung diseases: unresolved issues. Semin Respir Crit Care Med 2016; 37 (03) 468-476
• 21 Umashankar E, Abdel-Shaheed C, Plit M, Girgis L. Assessing the role for nailfold videocapillaroscopy in interstitial lung disease classification: a systematic review and meta-analysis. Rheumatology (Oxford) 2022; 61 (06) 2221-2234
• 22 Raghu G, Collard HR, Egan JJ. et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183 (06) 788-824
• 23 Gibson GJ, Pride NB, Davis J, Schroter RC. Exponential description of the static pressure-volume curve of normal and diseased lungs. Am Rev Respir Dis 1979; 120 (04) 799-811
• 24 Gottlieb D, Snider G. Lung function in pulmonary fibrosis. In: Phan S, Thrall R. eds. Lung Biology in Health and Disease: Pulmonary Fibrosis. New York: Marcel Dekker; 1995: 85-135
• 25 Arcadu A, Ryu JH. Constrictive (obliterative) bronchiolitis as presenting manifestation of connective tissue diseases. J Clin Rheumatol 2020; 26 (05) 176-180
• 26 Radovanovic D, Santus P, Blasi F. et al. A comprehensive approach to lung function in bronchiectasis. Respir Med 2018; 145: 120-129
• 27 Vergnenègre A, Pugnere N, Antonini MT. et al. Airway obstruction and rheumatoid arthritis. Eur Respir J 1997; 10 (05) 1072-1078
• 28 Steen VD, Graham G, Conte C, Owens G, Medsger Jr TA. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992; 35 (07) 765-770
• 29 Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131 (03) 657-663
• 30 Jacob J, Song JW, Yoon HY. et al. Prevalence and effects of emphysema in never-smokers with rheumatoid arthritis interstitial lung disease. EBioMedicine 2018; 28: 303-310
• 31 Koo BS, Park KY, Lee HJ. et al. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther 2021; 23 (01) 100
• 32 Suliman YA, Dobrota R, Huscher D. et al. Brief report: Pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 2015; 67 (12) 3256-3261
• 33 Raghu G, Remy-Jardin M, Richeldi L. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2022; 205 (09) e18-e47
• 34 Goh NS, Hoyles RK, Denton CP. et al. Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol 2017; 69 (08) 1670-1678
• 35 Caron M, Hoa S, Hudson M, Schwartzman K, Steele R. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev 2018; 27 (148) 170102
• 36 Guler SA, Winstone TA, Murphy D. et al. Does systemic sclerosis–associated interstitial lung disease burn out? Specific phenotypes of disease progression. Ann Am Thorac Soc 2018; 15 (12) 1427-1433
• 37 Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL. Progressive decline of lung function in rheumatoid arthritis–associated interstitial lung disease. Arthritis Rheumatol 2017; 69 (03) 542-549
• 38 Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology 2014; 19 (04) 493-500
• 39 Chang SH, Lee JS, Ha Y-J. et al. Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford) 2023; 62 (09) 3014-3024
• 40 Kalluri M, Oddis CV. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 2010; 31 (03) 501-512
• 41 Villalba WO, Sampaio-Barros PD, Pereira MC. et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest 2007; 131 (01) 217-222
• 42 Saleem F, Ryerson CJ, Sarma N. et al. Predicting new-onset exertional and resting hypoxemia in fibrotic interstitial lung disease. Ann Am Thorac Soc 2023; 20 (12) 1726-1734
• 43 Hobbs S, Chung JH, Leb J, Kaproth-Joslin K, Lynch DA. Practical imaging interpretation in patients suspected of having idiopathic pulmonary fibrosis: official recommendations from the Radiology Working Group of the Pulmonary Fibrosis Foundation. Radiol Cardiothorac Imaging 2021; 3 (01) e200279
• 44 Raghu G, Remy-Jardin M, Myers JL. et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198 (05) e44-e68
• 45 Assayag D, Elicker BM, Urbania TH. et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 2014; 270 (02) 583-588
• 46 Henry TS, Little BP, Veeraraghavan S, Bhalla S, Elicker BM. The spectrum of interstitial lung disease in connective tissue disease. J Thorac Imaging 2016; 31 (02) 65-77
• 47 Lee H-K, Kim DS, Yoo B. et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127 (06) 2019-2027
• 48 Moua T, Zamora Martinez AC, Baqir M, Vassallo R, Limper AH, Ryu JH. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res 2014; 15 (01) 154
• 49 Kligerman SJ, Groshong S, Brown KK, Lynch DA. Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations. Radiographics 2009; 29 (01) 73-87
• 50 Bouros D, Wells AU, Nicholson AG. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165 (12) 1581-1586
• 51 Kim DS, Yoo B, Lee JS. et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19 (02) 121-127
• 52 Debray M-P, Borie R, Revel M-P. et al. Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings. Eur J Radiol 2015; 84 (03) 516-523
• 53 Fraune C, Churg A, Yi ES. et al. Lymphoid interstitial pneumonia (LIP) revisited: a critical reappraisal of the histologic spectrum of “radiologic” and “pathologic” LIP in the context of diffuse benign lymphoid proliferations of the lung. Am J Surg Pathol 2023; 47 (03) 281-295
• 54 Chung JH, Cox CW, Montner SM. et al. CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease–associated interstitial lung disease from idiopathic pulmonary fibrosis. AJR Am J Roentgenol 2018; 210 (02) 307-313
• 55 Walkoff L, White DB, Chung JH, Asante D, Cox CW. The Four Corners Sign: a specific imaging feature in differentiating systemic sclerosis-related interstitial lung disease from idiopathic pulmonary fibrosis. J Thorac Imaging 2018; 33 (03) 197-203
• 56 Brady D, Berkowitz EA, Sharma A. et al. CT morphologic characteristics and variant patterns of interstitial pulmonary fibrosis in systemic lupus erythematosus. Radiol Cardiothorac Imaging 2021; 3 (04) e200625
• 57 Remy-Jardin M, Ryerson CJ, Schiebler ML. et al. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J 2021; 57 (01) 2004455
• 58 Capobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GS. Thoracic manifestations of collagen vascular diseases. Radiographics 2012; 32 (01) 33-50
• 59 Goh NS, Desai SR, Veeraraghavan S. et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177 (11) 1248-1254
• 60 Wells AU. Interstitial lung disease in systemic sclerosis. Presse Med 2014; 43 (10 Pt 2): e329-e343
• 61 Suman G, Koo CW. Recent advancements in computed tomography assessment of fibrotic interstitial lung diseases. J Thorac Imaging 2023; 38 (Suppl. 01) S7-S18
• 62 Chung JH, Adegunsoye A, Cannon B. et al. Differentiation of idiopathic pulmonary fibrosis from connective tissue disease-related interstitial lung disease using quantitative imaging. J Clin Med 2021; 10 (12) 2663
• 63 Chung JH, Adegunsoye A, Oldham JM. et al. Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol 2021; 31 (10) 7295-7302
• 64 Crews MS, Bartholmai BJ, Adegunsoye A. et al. Automated CT analysis of major forms of interstitial lung disease. J Clin Med 2020; 9 (11) 3776
• 65 Ohno Y, Aoyagi K, Takenaka D. et al. Machine learning for lung texture analysis on thin-section CT: Capability for assessments of disease severity and therapeutic effect for connective tissue disease patients in comparison with expert panel evaluations. Acta Radiol 2022; 63 (10) 1363-1373
• 66 Sun D, Wang Y, Liu Q. et al. Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease. Respir Res 2022; 23 (01) 4
• 67 Jamal F, Shashi K, Vaz N, Doyle T, Dellaripa P, Hammer M. Quantitative chest computed tomography for progression of interstitial lung disease in antisynthetase patients. J Thorac Imaging 2023; 10: 1097
• 68 Kondoh Y, Makino S, Ogura T. et al. joint committee of Japanese Respiratory Society and Japan College of Rheumatology. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig 2021; 59 (06) 709-740
• 69 Kowal-Bielecka O, Kowal K, Chyczewska E. Utility of bronchoalveolar lavage in evaluation of patients with connective tissue diseases. Clin Chest Med 2010; 31 (03) 423-431
• 70 Jee AS, Sheehy R, Hopkins P. et al. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand. Respirology 2021; 26 (01) 23-51
• 71 Hunninghake GW, Zimmerman MB, Schwartz DA. et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164 (02) 193-196
• 72 Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB. In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med 2016; 193 (10) 1161-1167
• 73 Lentz RJ, Argento AC, Colby TV, Rickman OB, Maldonado F. Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges. J Thorac Dis 2017; 9 (07) 2186-2203
• 74 Maldonado F, Danoff SK, Wells AU. et al. Transbronchial cryobiopsy for the diagnosis of interstitial lung diseases: CHEST Guideline and Expert Panel Report. Chest 2020; 157 (04) 1030-1042
• 75 Troy LK, Grainge C, Corte TJ. et al. Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease alliance (COLDICE) Investigators. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med 2020; 8 (02) 171-181
• 76 Schneider F, Gruden J, Tazelaar HD, Leslie KO. Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 2012; 136 (10) 1242-1252
• 77 Flaherty KR, King Jr TE, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 2004; 170 (08) 904-910
• 78 Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: a review. Front Med (Lausanne) 2022; 9: 1017501
• 79 Jo HE, Glaspole IN, Levin KC. et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 2016; 21 (08) 1438-1444
• 80 Teoh AKY, Holland AE, Morisset J. et al. ILD MDM Delphi Collaborators. Essential features of an interstitial lung disease multidisciplinary meeting: An International Delphi Survey. Ann Am Thorac Soc 2022; 19 (01) 66-73
• 81 De Sadeleer LJ, Meert C, Yserbyt J. et al. Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases. Chest 2018; 153 (06) 1416-1423
• 82 Walsh SLF, Wells AU, Desai SR. et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 2016; 4 (07) 557-565
• 83 Richeldi L, Launders N, Martinez F. et al. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ Open Res 2019; 5 (02) 00209-2018
• 84 Bosello SL, Beretta L, Del Papa N. et al. Interstitial lung disease associated with autoimmune rheumatic diseases: checklists for clinical practice. Front Med (Lausanne) 2021; 8: 732761
• 85 De Lorenzis E, Bosello SL, Varone F. et al. Multidisciplinary evaluation of interstitial lung diseases: new opportunities linked to rheumatologist involvement. Diagnostics (Basel) 2020; 10 (09) 664
• 86 Khanna D, Mittoo S, Aggarwal R. et al. Connective tissue disease-associated interstitial lung diseases (CTD-ILD)—report from OMERACT CTD-ILD Working Group. J Rheumatol 2015; 42 (11) 2168-2171
• 87 Mittoo S, Frankel S, LeSage D. et al. Patient perspectives in OMERACT provide an anchor for future metric development and improved approaches to healthcare delivery in connective tissue disease related interstitial lung disease (CTD-ILD). Curr Respir Med Rev 2015; 11 (02) 175-183
• 88 Swigris JJ, Brown KK, Abdulqawi R. et al. Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. Eur Respir Rev 2018; 27 (150) 180075
• 89 Belkin A, Albright K, Swigris JJ. A qualitative study of informal caregivers' perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respir Res 2014; 1 (01) e000007
• 90 Jokerst C, Purdy H, Bhalla S. An overview of collagen vascular disease-associated interstitial lung disease. Semin Roentgenol 2015; 50 (01) 31-39
• 91 Zanatta E, Cocconcelli E, Castelli G. et al. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. RMD Open 2023; 9 (03) e003121
• 92 Egashira R, Kondo T, Hirai T. et al. CT findings of thoracic manifestations of primary Sjögren syndrome: radiologic-pathologic correlation. Radiographics 2013; 33 (07) 1933-1949